Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01038232 · ClinicalTrials.gov registry record

Measuring Distress Tolerance With Functional MRI

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
99
Enrollment target

NCT01038232 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 99 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01038232 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
99 participants
Enrollment target

Study Summary

Background: \- People who are in treatment for substance abuse often feel distress during the withdrawal period and afterward. Some individuals feel distress more acutely than others, and this distress has been linked to poor treatment outcomes and increased risk of relapse in smokers, alcoholics, and cocaine- and heroin-dependent individuals. More research is needed on the effects of distress on the brain, particularly in individuals who are seeking treatment for substance abuse. Researchers are interested in using functional magnetic resonance imaging (fMRI) scanning to study distress tolerance in both substance users seeking treatment and healthy non-drug-using volunteers. Objectives: \- To use functional magnetic resonance imaging to study the effectiveness of a distress tolerance assessment. Eligibility: \- Individuals between 18 and 50 years of age who are either cocaine dependent or healthy non-drug-using volunteers. Design: * This study involves an initial screening visit and a scanning visit, with four followup visits. * Participants will be screened with a medical history and physical examination, as well as blood samples and questionnaires about mood and past and current drug use. * Participants will have a structural MRI scan of the brain to provide a baseline reading for comparison. Participants will then have an fMRI scanning session, which will include both the distress tolerance assessment and relevant control tasks. Heart rate, blood pressure, and other physical reactions will be monitored throughout the scan. Participants will also provide blood and saliva samples to measure stress hormone levels. * Participants will be eligible to have followup assessments with fMRI scanning 1, 3, 6, and 12 months after the scanning visit.

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2009-12-04
Est. Completion 2015-03-24

What the Registry Record Tells You About NCT01038232

The ClinicalTrials.gov registry entry for NCT01038232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01038232 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01038232 about?

NCT01038232 is a clinical study titled "Measuring Distress Tolerance With Functional MRI". Background: \- People who are in treatment for substance abuse often feel distress during the withdrawal period and afterward. Some individuals feel distress more acutely than others, and this distress has been linked to poor treatment outcomes and increased risk of relapse in smokers, alcoholics, ...

What is the current status of trial NCT01038232?

This trial is currently completed. The enrollment target is 99 participants. The study started on 2009-12-04. Estimated completion is 2015-03-24.

Who is sponsoring clinical trial NCT01038232?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.